Hutch News

Hutch News

Stories tagged 'antibodies'

Bringing a leukemia treatment back to life with precision medicine

New research writes latest chapter in one drug's story

June 27, 2017 | by Susan Keown / Fred Hutch News Service

The leukemia drug gemtuzumab ozogamicin (Mylotarg) was pulled from the market seven years after initial approval. Now, new evidence may be bringing it back to life to treat a specific group of patients.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Dec. 8, 2016

Good News: $475K gift fuels expansion of antibody technology; Dr. Hansen honored for BMT work; Senate passes 21st Century Cures Act, sends to Obama

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Oct. 13, 2016

Dr. David Maloney named cellular immunotherapy medical director at Fred Hutch, SCCA; Dr. Jim Kublin gets grant to study how gut bugs alter HIV vaccine response.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

June 24, 2016

View story >


Good News at Fred Hutch

Dr. Roland Walter receives two grant awards for acute leukemia research; Dr. Jonathan Bricker to keynote behavioral therapy conference; Dr. Benjamin Anderson chairs NCCN committee that publishes clinical-practice guidelines for cervical cancer

Aug. 27, 2015 | By Fred Hutch staff

Dr. Roland Walter receives two grant awards for acute leukemia research; Dr. Jonathan Bricker to keynote behavioral therapy conference; Dr. Benjamin Anderson chairs NCCN committee that publishes clinical-practice guidelines for cervical cancer

View story >


HIV cure research today: Gene therapy, molecular scissors and Where’s Waldo

More than 100 researchers gather at second annual Fred Hutch conference

Aug. 14, 2015 | By Mary Engel / Fred Hutch News Service

From across the country, HIV experts and cancer researchers who have devoted their careers to improving stem cell transplants came together at Fred Hutchinson Cancer Research Center Thursday and Friday. Their goal? To talk about how to translate the world’s only known person to be cured of HIV to a cure or long-term remission that is less risky, less costly and broadly applicable to the millions worldwide now living with the virus.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.